The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A Statewide Survey of Practitioners to Assess Knowledge and Clinical Practices Regarding Hereditary Breast and Ovarian Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Barriers to family history screening and genetic counseling referral include insufficient knowledge of HBOC and inability to intuit risk, [31–35] lack of time and competing priorities in the primary care encounter, [30, 36] and inadequate reporting of family history in medical records [26, 37].”
From Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care (2018) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Research works printed but not linked: 34
- 10.3758/BF03206411 · DOI
- 10.1097/GIM.0b013e31821882b7 · DOI
- Brierley KL, 2010, Conn Med, 74, 413
- 10.1136/hrt.2009.190090 · doi:10.1136/hrt.2009.190090
- 10.1016/j.jmoldx.2012.06.003 · DOI
- 10.1007/s10897-009-9243-y · doi:10.1007/s10897-009-9243-y
- 10.1097/01.GIM.0000055198.63593.32 · DOI
- 10.1200/JCO.2007.14.4154 · doi:10.1200/jco.2007.14.4154
- 10.1001/jama.2010.1263 · DOI
- Forum NCP, 2007, Cancer-Related Genetic Testing and Counseling: Workshop Proceedings
- 10.1097/AOG.0b013e3181a106d4 · DOI · Paper page
- 10.1038/nbt0906-1083 · DOI
- 10.1016/S0968-8080(01)90089-8 · DOI
- Jaen CR, 1994, J Fam Pract, 38, 166
- 10.1002/cncr.27556 · DOI
- 10.1200/JCO.2008.17.8053 · DOI
- 10.1080/15265160802248179 · DOI
- 10.1097/GIM.0b013e318182206f · DOI
- 10.1097/01.gim.0000223544.68475.6c · DOI
- 10.1007/s10549-009-0607-7 · DOI
- 10.1002/cncr.21536 · DOI · Paper page
- Pal T, Community Oncology
- 10.1002/1096-8628(20010101)98:1<3::AID-AJMG1012>3.0.CO;2-Y · DOI
- 10.1097/GIM.0b013e318207f564 · doi:10.1097/gim.0b013e318207f564
- 10.1038/ejhg.2008.93 · doi:10.1038/ejhg.2008.93
- 10.1007/s10897-011-9462-x · DOI · Paper page
- 10.1200/JCO.2009.27.0660 · DOI · Paper page
- Rosenthal ET, 2007, Oncology Times, 29, 34
- 10.1016/j.cancergen.2011.07.005 · doi:10.1016/j.cancergen.2011.07.005
- 10.1001/jama.2011.678 · DOI
- 10.1002/ajmg.a.30681 · DOI
- 10.1177/1062860605274520 · DOI · Paper page
- 10.1089/gtmb.2009.0037 · doi:10.1089/gtmb.2009.0037
- 10.1136/jmg.2004.030296 · DOI
Cited by
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Cortesi, L., Rugo, H. S., & Jackisch, C. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00796-4 · Cited by 393
Samadder, N. J., Riegert-Johnson, D., Boardman, L., Rhodes, D., Wick, M., Okuno, S., Kunze, K. L., Golafshar, M., Uson, P. L. S., Mountjoy, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6252 · Cited by 304
Silverman, T. B., Vanegas, A., Marte, A., Mata, J., Sin, M., Ramirez, J. C. R., Tsai, W.-Y., Crew, K. D., & Kukafka, R. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3442-x · Cited by 19
Metadata
- Authors
- Pal, T., Cragun, D., Lewis, C., Doty, A., Rodriguez, M., Radford, C., Thompson, Z., Kim, J., & Vadaparampil, S. T.
- Venue
- Genetic Testing and Molecular Biomarkers
- Publisher
- SAGE Publications
- Published
- 2013-05
- Volume
- 17
- Issue
- 5
- Pages
- 367-375
- ISSN
- 1945-0265
- 1945-0257
- Cited by
- 56
- References
- 2
- Language
- en
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.